Joh. Berenberg Gossler & Co. KG covered Merck (ETR:MRK), upping its target price to 101.00EUR today
- Updated: October 14, 2016
Merck (ETR:MRK) had its target upped to 101.00EUR by Joh. Berenberg Gossler & Co. KG in an issued report announced Saturday October 15, 2016. The bumped up target suggests a potential upside of 0.03% based on the company's previous stock price.
On Friday October 14, 2016, Joh. Berenberg Gossler & Co. KG released a statement about Merck (ETR:MRK) upped the target price from 0.00EUR to 101.00EUR that suggested an upside of 0.03%.
Having a price of 97.63EUR, Merck (ETR:MRK) traded -0.59% lower on the day. With the last stock price up 5.98% from the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.01% over the same period. MRK has recorded a 50-day average of 62.57EUR and a two hundred day average of 58.63EUR. Trade Volume was up over the average, with 12,204,208 shares of MRK changing hands over the typical 10,050,800
Recent Performance Chart
Merck has PE ratio of 34.09 with a one year low of 47.97EUR and a one year high of 64.86EUR and has a market capitalization of 0 EUR.
A total of 20 equity analysts have released a ratings update on MRK. 2 firms rating the stock a strong buy, 7 brokerages rating the company a buy, thirteen analysts rating the company a hold, zero firms rating the stock a underperform, and finally 0 brokers rating the stock a sell with a average stock price target of 61.60EUR.
General Information About Merck (ETR:MRK)
Merck KGaA is a Germany-based company engaged in the pharmaceutical industry. The Company diversifies its activities into four business divisions: Merck Serono; Consumer Health; Merck Millipore, and Performance Materials. Within the Merck Serono division, the Company focuses on therapeutic areas and prescription drugs of chemical and biotechnological origin. The Consumer Health division comprises the over-the-counter products for preventive health care and self-treatment of minor ailments. The Merck Serono and Consumer Health divisions form together the Company's Pharmaceutical business sector. The Merck Millipore division comprises the activities of the Millipore Corporation. The Performance Materials division consists mainly of the Liquid Crystals and Pigments & Cosmetics business units. The Company operates through numerous subsidiaries, including Peer+ BV, AZ Electronic Materials (AZ) and Ormet Circuits Inc., a material supplier for the semiconductor industry.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.